ConferenceAmerican Journal of Respiratory and Critical Care Medicine · June 1, 2026
AbstractRationaleThe diagnostic yield of conventional bronchoscopic transbronchial biopsy using forceps for the evaluation of p ...
Full textCite
ConferenceAmerican Journal of Respiratory and Critical Care Medicine · May 1, 2026
AbstractRationaleObesity, a prevalent comorbidity of asthma, worsens disease severity and blunts responses to asthma therapies. ...
Full textCite
ConferenceAmerican Journal of Respiratory and Critical Care Medicine · May 1, 2026
AbstractRationaleAccurate longitudinal tracking and volume quantification of lung nodules are critical for risk stratification ...
Full textCite
ConferenceAmerican Journal of Respiratory and Critical Care Medicine · May 1, 2026
AbstractRationaleSybil is a deep learning model developed for early lung cancer prediction using low dose Computed tomography ( ...
Full textCite
ConferenceAmerican Journal of Respiratory and Critical Care Medicine · May 1, 2026
AbstractRationaleObesity increases the severity of asthma and modifies airway pathobiology, contributing to a lack of responsiv ...
Full textCite
ConferenceAmerican Journal of Respiratory and Critical Care Medicine · May 1, 2025
AbstractRationale: Lung cancer screening (LCS) uptake in the United States remains low with substantial economic and racial disparities in LCS rates, even among centralized LCS programs like that within t ...
Full textCite
ConferenceAmerican Journal of Respiratory and Critical Care Medicine · May 1, 2025
AbstractRationale: Despite completing treatment, lung cancer survivors frequently experience symptoms of dyspnea, fatigue, depression and anxiety. We previously demonstrated that a comprehensive 12-week s ...
Full textCite
ConferenceAmerican Journal of Respiratory and Critical Care Medicine · May 1, 2025
AbstractINTRODUCTION: Primary pleural neoplasms are infrequently encountered in clinical practice with pleural involvement far more likely to occur because of metastatic disease. Malignant pleural mesothe ...
Full textCite
ConferenceCancer Research · May 2, 2024
AbstractBackground: In the DESTINY-BREAST studies, Trastuzumab deruxtecan (T-DXd) demonstrated significant antitumor activity in heavily pretreated patients (pts) with HER2-positive and HER2-low advanced bre ...
Full textCite